Multiple System Atrophy
Multiple System Atrophy (MSA) is a rare neurological disorder that affects the body's autonomic functions, leading to symptoms such as balance issues, muscle rigidity, and problems with coordination.
We are testing the medication Lu AF82422 to see if it can slow disease progression in people with Multiple System Atrophy. The study will also look at its effects on overall health and quality of life.
Health conditions and diseases that the clinical trial is designed to study and treat.
Multiple System Atrophy (MSA) is a rare neurological disorder that affects the body's autonomic functions, leading to symptoms such as balance issues, muscle rigidity, and problems with coordination.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.